Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?

por Bourlière, Marc, Pietri, Olivia, Castellani, Paul, Oules, Valérie, Adhoute, Xavier
Publicado 2018

Chronic hepatitis C: future treatment

por Wendt, Astrid, Adhoute, Xavier, Castellani, Paul, Oules, Valerie, Ansaldi, Christelle, Benali, Souad, Bourlière, Marc
Publicado 2014

Detection of IL28B SNP DNA from Buccal Epithelial Cells, Small Amounts of Serum, and Dried Blood Spots

por Halfon, Philippe, Ouzan, Denis, Khiri, Hacène, Pénaranda, Guillaume, Castellani, Paul, Oulès, Valerie, Kahloun, Asma, Amrani, Nolwenn, Fanteria, Lise, Martineau, Agnès, Naldi, Lou, Bourlière, Marc
Publicado 2012

Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching

por Adhoute, Xavier, De Matharel, Marie, Mineur, Laurent, Pénaranda, Guillaume, Ouizeman, Dann, Toullec, Clemence, Tran, Albert, Castellani, Paul, Rollet, Armelle, Oules, Valérie, Perrier, Hervé, Si Ahmed, Si Nafa, Bourliere, Marc, Anty, Rodolphe
Publicado 2022